Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward? | Immunotherapy;6(2): 109-11, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward?

Almeida, Joao Paulo Mattos; Drezek, Rebekah A; Foster, Aaron E.

Affiliation

Almeida JP; Department of Bioengineering, Rice University, Houston, TX, USA.

Immunotherapy ; 6(2): 109-11, 2014.

Article in En | MEDLINE | ID: mdl-24491082

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Ablation Techniques / Immunity / Immunotherapy / Melanoma Limits: Animals / Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Ablation Techniques / Immunity / Immunotherapy / Melanoma Limits: Animals / Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2014 Document type: Article Affiliation country: Estados Unidos